Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

nhsyyy

Number of people waiting for NHS treatment could double to 10 million due to pandemic

June 10, 2020 Research and Development COVID-19, coronavirus

The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …
News
vertex-headquarters

Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents

June 10, 2020 Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma

Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 10, 2020 Research and Development COVID-19, coronavirus, round up, top 10

Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …
News

Lundbeck to restructure R&D, shedding up to 160 jobs

June 10, 2020 Manufacturing and Production, Research and Development Lundbeck, pharma, staff cuts

Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a …
News
triallyyy

US trial of ivermectin cuts coronavirus mortality by 40%

June 10, 2020 Research and Development COVID-19, coronavirus

A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%. …
News
alnylam_credit_-_business_wire

Alnylam’s lumasiran hits main Phase 3 goal in rare renal disease primary hyperoxaluria type 1

June 9, 2020 Manufacturing and Production, Research and Development Alnylam, lumasiran, pharma, rare disease

Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International Congress for …
News
astrazeneca_sign_sky

AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients

June 8, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
News
stacey

Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …
News
novartis_outside_1

Novartis’ Cosentyx hits primary goal in Phase 3 non-radiographic axial spondyloarthritis study

June 4, 2020 Research and Development Cosentyx, Novartis, axial spondyloarthritis

New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the …
News
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya shows skin clearance benefit for psoriatic arthritis patients in two Phase 3 studies

June 4, 2020 Research and Development Janssen, Tremfya, psoriatic arthritis

Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in …
News
remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020 Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
News
chloroquine

Lancet expresses concern over published hydroxychloroquine and chloroquine paper

June 3, 2020 Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …
News
fda

The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening

June 3, 2020 Research and Development AAPS, COVID-19, coronaviryus

The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …
News
ibuprofen

Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients

June 3, 2020 Research and Development COVID-19, coronavirus, ibuprofen

Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025